LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 61.56 | 27.76 | 2141 | 6217 | 0.3444 | 0.7447 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 61.56 | 27.76 | 6118 | 6217 | 0.9840 | 0.9959 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.26 | 27.76 | 5308 | 6465 | 0.8210 | 0.9505 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.26 | 27.76 | 5341 | 6465 | 0.8261 | 0.9520 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.26 | 27.76 | 2111 | 6465 | 0.3265 | 0.7347 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.26 | 27.76 | 6396 | 6465 | 0.9892 | 0.9973 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.97 | 27.76 | 5627 | 6656 | 0.8453 | 0.9579 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.97 | 27.76 | 5652 | 6656 | 0.8491 | 0.9590 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.97 | 27.76 | 2340 | 6656 | 0.3515 | 0.7523 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.97 | 27.76 | 6616 | 6656 | 0.9939 | 0.9985 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 66.67 | 27.76 | 5797 | 6695 | 0.8658 | 0.9639 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 66.67 | 27.76 | 5833 | 6695 | 0.8712 | 0.9654 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 66.67 | 27.76 | 2466 | 6695 | 0.3683 | 0.7629 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 66.67 | 27.76 | 6947 | 6695 | 1.0375 | 1.0093 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 68.37 | 27.76 | 6037 | 6879 | 0.8776 | 0.9674 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 68.37 | 27.76 | 6072 | 6879 | 0.8827 | 0.9689 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 68.37 | 27.76 | 2680 | 6879 | 0.3896 | 0.7765 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 68.37 | 27.76 | 7226 | 6879 | 1.0504 | 1.0124 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.08 | 27.76 | 6213 | 6849 | 0.9071 | 0.9756 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.08 | 27.76 | 6252 | 6849 | 0.9127 | 0.9772 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.08 | 27.76 | 2554 | 6849 | 0.3729 | 0.7665 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.08 | 27.76 | 7435 | 6849 | 1.0854 | 1.0207 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 71.78 | 27.76 | 6447 | 6893 | 0.9353 | 0.9833 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 71.78 | 27.76 | 6487 | 6893 | 0.9411 | 0.9848 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 71.78 | 27.76 | 2454 | 6893 | 0.3560 | 0.7565 | MN20160318_Q01 | M17 |